PICCOLO trial met its primary endpoint of objective response rate (ORR) Data from the study will be presented at a future medical meeting NORTH CHICAGO, Ill., June 6, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) announced today positive topline results from the Phase 2 PICCOLO trial…

The rise of Chinese suppliers will change the game CAMPBELL, Calif., June 6, 2024 /PRNewswire/ — Mobile Experts released its definitive report on the Radio Frequency Front End market for smartphones today, including clear predictions about the future direction of shipments and revenue…